BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Apoptosis
,
Breast Cancer
,
Lung
,
Laryngoscope
,
Lovastatin
,
rs6983267
,
MYC
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
receptor Tie-2
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for receptor Tie-2
Explore Curated Studies Results
Literature
Most Relevant Literature
An engineered tetra-valent antibody fully activates the Tie2 receptor with comparable potency to its…
Adaptor Protein ShcD/SHC4 Interacts with Tie2 Receptor to Synergistically Promote Glioma Cell Invasi…
Structural insights into the clustering and activation of Tie2 receptor mediated by Tie2 agonistic a…
Are TEMs Canceled? Questioning the Functional Relevance of Tie2-Expressing Macrophages.
Mapping Angiopoietin1 Expression in the Developing and Adult Brain.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Role of Angiopoietin, Tie-2, and Vascular Endothelial Growth Factor (VEGF) in Sepsis-Induced Mul…
Citalopram Effects on Craving and Dopamine Receptor Availability in Alcoholics
Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Prima…
Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-N…
Vascular Injury in Mechanical Ventilation: a Proof-of-Concept Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ